We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-6.15%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.22B
AUM Growth
-$360M
Cap. Flow
-$44.9M
Cap. Flow %
-2.02%
Top 10 Hldgs %
20.17%
Holding
274
New
20
Increased
66
Reduced
133
Closed
31

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$22.9M
2
LTH icon
Life Time Group Holdings
LTH
+$19.4M
3
VSEC icon
VSE Corp
VSEC
+$17.6M
4
ETNB
89bio
ETNB
+$13.6M
5
WSBC icon
WesBanco
WSBC
+$12.3M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$36.6M
2
FTAI icon
FTAI Aviation
FTAI
+$17.2M
3
NOG icon
Northern Oil and Gas
NOG
+$15.6M
4
FULT icon
Fulton Financial
FULT
+$14.4M
5
NVEE
NV5 Global
NVEE
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.67%
2 Technology 23.1%
3 Industrials 18.7%
4 Financials 15.06%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVER icon
76
EverQuote
EVER
$925M
$11.6M 0.52%
+443,701
New +$10.2M
OSW icon
77
OneSpaWorld
OSW
$2.68B
$11.4M 0.51%
680,178
+261,701
+63% +$5.09M
WSBC icon
78
WesBanco
WSBC
$3.92B
$11.4M 0.51%
+368,816
New +$12.3M
ETNB
79
DELISTED
89bio
ETNB
$11.3M 0.51%
+1,550,671
New +$13.6M
LIF
80
Life360
LIF
$4.36B
$10.4M 0.47%
270,817
+94,679
+54% +$4.08M
KALV
81
DELISTED
KalVista Pharmaceuticals
KALV
$10.4M 0.47%
898,190
+62,140
+7% +$634K
NVCR icon
82
NovoCure
NVCR
$1.84B
$9.59M 0.43%
538,249
-9,308
-2% -$211K
BOW
83
Bowhead Specialty Holdings
BOW
$1.01B
$9.59M 0.43%
235,853
-4,613
-2% -$157K
NSSC icon
84
Napco Security Technologies
NSSC
$1.29B
$9.4M 0.42%
408,485
-126,607
-24% -$3.59M
AAOI icon
85
Applied Optoelectronics
AAOI
$8.22B
$9.15M 0.41%
596,376
-10,621
-2% -$267K
WHD icon
86
Cactus
WHD
$3.78B
$8.85M 0.4%
193,061
-114,254
-37% -$6.33M
SYRE icon
87
Spyre Therapeutics
SYRE
$8.7B
$8.84M 0.4%
547,827
+1,036
+0.2% +$21.6K
INR
88
Infinity Natural Resources
INR
$244M
$8.72M 0.39%
+465,174
New +$8.72M
SVRA icon
89
Savara
SVRA
$1.13B
$8.56M 0.39%
3,090,213
+757,533
+32% +$2.09M
BHVN icon
90
Biohaven
BHVN
$2.32B
$8.53M 0.38%
354,953
-5,585
-2% -$197K
BUSE icon
91
First Busey Corp
BUSE
$2.54B
$8.33M 0.37%
385,500
-1,226
-0.3% -$28.5K
NEO icon
92
NeoGenomics
NEO
$1.9B
$8.12M 0.37%
855,688
-701,749
-45% -$8.76M
RSI icon
93
Rush Street Interactive
RSI
$3.35B
$8.12M 0.37%
757,477
+30,988
+4% +$407K
ABCB icon
94
Ameris Bancorp
ABCB
$6.21B
$7.83M 0.35%
+136,058
New +$8.49M
FULT icon
95
Fulton Financial
FULT
$4.74B
$7.8M 0.35%
431,147
-739,773
-63% -$14.4M
PWP icon
96
Perella Weinberg Partners
PWP
$1.16B
$7.42M 0.33%
+403,280
New +$9.15M
SOC icon
97
Sable Offshore Corp
SOC
$834M
$7.38M 0.33%
291,024
-1,548
-0.5% -$39.6K
CVRX icon
98
CVRx
CVRX
$130M
$7.23M 0.33%
590,850
-3,048
-0.5% -$43K
CORT icon
99
Corcept Therapeutics
CORT
$9.72B
$7.1M 0.32%
+62,182
New +$3.78M
SKYT icon
100
SkyWater Technology
SKYT
$1.54B
$7.1M 0.32%
1,000,716
+12,562
+1% +$123K
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Emerald Advisers held 274 positions worth $2.22B, down 14% from $2.58B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q1 2025 filing shows 20 new, 66 increased, 133 reduced and 31 closed positions. Its largest new stake was Guardant Health: 531,424 shares worth $22.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Emerald Advisers's largest Q1 2025 buy was Guardant Health: 531,424 shares worth $22.6M.
  • Emerald Advisers added most to The Bancorp in Q1 2025, an estimated $11.8M increase.
  • Emerald Advisers's biggest Q1 2025 reduction was FTAI Aviation, cutting an estimated $17.2M.
  • Emerald Advisers fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $36.6M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.22B portfolio in Q1 2025.
  • Emerald Advisers opened 20 new positions and closed 31 in Q1 2025.
  • Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.22B.

Based on Emerald Advisers's 13F filing for Q1 2025, filed 1 May 2025.